Isomorphic Labs Raises $5 Billion to Push AI Drugs Toward Trials

Reading Time : 3 minutesIsomorphic Labs has raised $5 billion to accelerate its effort to turn AI-driven protein science into real medicines. Backed by Sequoia, Greenoaks, and Alphabet, the company says its technology is approaching a pivotal test: moving its first drug candidates into clinical trials by the end of 2026.